Cardiac Fibroblast Isolation and Phenotype Modulation
Corresponding Organization :
Other organizations : KU Leuven
Variable analysis
- Treatment with recombinant human TGF-β1 (400 pmol/L) to promote differentiation
- Treatment with SD-208 (3 μmol/L), a specific TGF-β-receptor-I (TGF-β-RI) kinase inhibitor to suppress differentiation
- Protein expression and morphology of the fibroblasts
- Capacity for proliferation, migration, and contraction of a floating gel
- Cell seeding density (3000 cells/cm^2)
- Culture medium (DMEM with 10% FBS and 1% penicillin/streptomycin)
- Duration of treatment (6 days)
- Positive control: Fibroblasts treated with recombinant human TGF-β1 to promote differentiation
- Negative control: Fibroblasts treated with SD-208, a TGF-β-receptor-I kinase inhibitor, to suppress differentiation
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!